For research use only. Not for therapeutic Use.
Travoprost is an F-<wbr></wbr>series prostaglandin analog which has been approved for use as an ocular hypotensive drug. Oxidation of the C-<wbr></wbr>15 hydroxyl group without isopropyl ester hydrolysis produces 15-<wbr></wbr>keto fluprostenol isopropyl ester (15-<wbr></wbr>keto travoprost). 15-<wbr></wbr>keto Travoprost is a potential metabolite of travoprost when administered to intact animals. 15-<wbr></wbr>keto Travoprost is also one of the common minor impurities found in commercial preparations of the bulk drug compound. In general, F-<wbr></wbr>series prostaglandin analogs with a 15-<wbr></wbr>keto functional group lose a great deal of their FP receptor binding affinity, but retain enough to show a continued weak IOP hypotensive response. The efficacy of 15-<wbr></wbr>keto travoprost as an ocular hypotensive has not been established.
Catalog Number | R053380 |
CAS Number | 404830-45-1 |
Synonyms | (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic Acid 1-Methylethyl Ester; 15-keto Fluprostenol Isopropyl Ester; |
Molecular Formula | C26H33F3O6 |
Purity | ≥95% |
Target | Drug Metabolite |
Storage | -20°C |
InChIKey | KSDDYCRRTVADFZ-OHDKTVHDSA-N |